| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0006-3223(88)90291-0 |
| P698 | PubMed publication ID | 3277676 |
| P2093 | author name string | Miles A | |
| Philbrick DR | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychiatry | Q7867 |
| melatonin | Q180912 | ||
| P304 | page(s) | 405-425 | |
| P577 | publication date | 1988-02-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Melatonin and psychiatry | |
| P478 | volume | 23 |
| Q33921141 | Age, alcoholism and depression are associated with low levels of urinary melatonin |
| Q51719842 | Analgesic nitrous oxide in alcohol withdrawal: the role of melatonin. |
| Q46764282 | Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine |
| Q41088457 | Cocaine addiction: relationship to seasonal affective disorder |
| Q46688212 | Coexisting bipolar affective disorder and multiple sclerosis: the role of the pineal gland |
| Q53335988 | Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type. |
| Q36446704 | Depression and coronary heart disease |
| Q48465098 | Dysmenorrhea and the pineal gland |
| Q34997754 | Functional plasticity of the circadian timing system in old age: light exposure |
| Q42720384 | Hormonal and behavioural abnormalities induced by stress in utero: an animal model for depression |
| Q48703440 | Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin |
| Q38224175 | Light, vitamin D and psychiatry. Role of 1,25 dihydroxyvitamin D3 (soltriol) in etiology and therapy of seasonal affective disorder and other mental processes |
| Q38749646 | Locus coeruleus-pineal melatonin interactions and the pathogenesis of the "on-off" phenomenon associated with mood changes and sensory symptoms in Parkinson's disease |
| Q28334481 | MIF-induced augmentation of melatonin functions: possible relevance to mechanisms of action of MIF-1 in movement disorders |
| Q35281460 | Magnetic fields and seasonality of affective illness: implications for therapy |
| Q38018551 | Mechanisms of action of ECT in Parkinson's disease: possible role of pineal melatonin |
| Q35243519 | Melatonin and petit-mal epilepsy: an hypothesis |
| Q44188616 | Melatonin response to atenolol administration in depression: indication of beta-adrenoceptor dysfunction in a subtype of depression |
| Q43711801 | Melatonin response to clonidine administration in depression: indication of presynaptic alpha2-adrenoceptor dysfunction. |
| Q41325314 | Melatonin supplements for aging |
| Q61800283 | Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits |
| Q36396126 | Melatonin: possible implications for the postoperative and critically ill patient |
| Q64946260 | Melatonine en stemmingsstoornissen. |
| Q48477916 | Modulation of plasma melatonin concentrations by changes in posture |
| Q89370032 | Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues |
| Q41216081 | Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin |
| Q50607498 | Multiple sclerosis: relationship between seasonal variations of relapse and age of onset. |
| Q40690927 | Multiple sclerosis: the role of puberty and the pineal gland in its pathogenesis |
| Q52270699 | Neuroendocrine aspects of primary endogenous depression. XV: Mathematical modeling of nocturnal melatonin secretion in major depressives and normal controls. |
| Q45098438 | Neuroradiological covariates of drug-induced parkinsonism and tardive dyskinesia in schizophrenia |
| Q35223138 | Nocturnal Plasma Melatonin and Alpha-Melanocyte Stimulating Hormone Levels During Exacerbation of Multiple Sclerosis |
| Q40690936 | Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders |
| Q43669659 | Nocturnal melatonin secretion in suicidal patients with multiple sclerosis |
| Q74667667 | Normative melatonin excretion: a multinational study |
| Q35680557 | Pharmacological modulation of circadian rhythms: a new drug target in psychotherapeutics |
| Q48416802 | Physiological concentrations of melatonin inhibit the norepinephrine-induced activation of prostaglandin E2 and cyclic AMP production in rat hypothalamus: a mechanism involving inhibiton of nitric oxide synthase |
| Q45045827 | Pineal Calcification in Relation to Menopause in Schizophrenia |
| Q38697214 | Pineal melatonin and sensory symptoms in Parkinson disease |
| Q38018546 | Pineal melatonin functions: possible relevance to Parkinson's disease |
| Q38015650 | Possible role of pineal melatonin in the mechanisms of aging |
| Q28332518 | Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient |
| Q48280336 | Rapid improvement of visuoperceptive functions by picoTesla range magnetic fields in patients with Parkinson's disease |
| Q36404444 | Red light and the sleep quality and endurance performance of Chinese female basketball players |
| Q48147091 | Relationship of nocturnal melatonin levels to duration and course of multiple sclerosis |
| Q40727514 | Reversal of visual neglect in Parkinson's disease by treatment with picoTesla range magnetic fields |
| Q26825564 | Role of melatonin in schizophrenia |
| Q52008733 | Seasonal pattern of melatonin excretion in humans: relationship to daylength variation rate and geomagnetic field fluctuations. |
| Q44630002 | Serum melatonin and urinary 6-sulfatoxymelatonin in major depression |
| Q52048628 | Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients. |
| Q53906609 | Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. |
| Q58305857 | Simultaneous Analysis of Pyridoxine and Melatonin in Tablet Formulation by Derivative Ultraviolet Spectroscopy |
| Q41175822 | Tardive dyskinesia associated with depression in a bipolar patient: possible role of melatonin |
| Q38018562 | Tardive dyskinesia in bipolar disorders: possible role of pineal melatonin |
| Q48505011 | The Pineal Gland and Multiple Sclerosis |
| Q48416890 | The Pineal Gland and the Mode of Onset of Schizophrenia |
| Q35223135 | The influence of the pineal gland on Migraine and cluster headaches and Effects of treatment with picotesla Magnetic fields |
| Q41163471 | The pineal gland, cataplexy, and multiple sclerosis |
| Q44667041 | The relationship between ECT nonresponsiveness and calcification of the pineal gland in bipolar patients |
| Q35281449 | The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome |
| Q48750806 | The relationship of pineal calcification to cortical atrophy in schizophrenia |
| Q48883288 | The relationship of pineal calcification to subtypes of tardive dyskinesia in bipolar patients |
| Q49014054 | The relationship of pineal calcification to tardive dyskinesia |
| Q35279982 | The role of melatonin in the antipsychotic and motor-side effects of neuroleptics: a hypothesis |
| Q35842103 | The therapeutic potential of melatonin: a review of the science |
| Q67483654 | Weak Magnetic Fields as a Novel Therapeutic Modality in Parkinson's Disease |
Search more.